AdaptHealth Shares Sink After Earnings Miss and Lower Full-Year Guidance
AdaptHealth Corp. (NASDAQ:AHCO) shares fell about 13% premarket after Q2 2026 results missed expectations and the company cut full-year guidance. It reported a net loss of $0.99 per share and revenue of $740.3M versus $848.9M expected. FY revenue guidance was lowered to $2.85B-$2.89B from about $3.49B, with adjusted EBITDA $490M-$520M and free cash flow $80M-$120M.
How this was made
The 30-second read
Why it matters
The combination of an earnings miss, large net loss driven by a goodwill impairment, and a broad guidance cut (revenue, adjusted EBITDA, and free cash flow) is likely to drive immediate repricing and heightened volatility.
Market read
Traders can act on a fresh earnings-and-guidance catalyst with explicit 2026 ranges and disclosed headwinds, explaining the pre-market selloff.
What to watch
The Diabetes Health business is classified as discontinued operations, so reported revenue comparisons and impairment effects may overstate ongoing operating weakness versus underlying continuing operations.
Background
AdaptHealth is a home medical equipment provider; the article centers on its Q2 2026 results, margin pressure, and a major guidance reduction for fiscal 2026.
Ticker impact
AdaptHealth (AHCO) shares fell nearly 13% pre-market after Q2 results missed expectations and full-year revenue, EBITDA, and FCF guidance were cut sharply.
Further downside volatility likely as investors reprice 2026 revenue, adjusted EBITDA, and free cash flow toward the lowered ranges.
The article reports a clear earnings miss (loss vs EPS expectation, revenue miss) plus materially lower full-year guidance and specific headwinds (discontinued Diabetes business, contract impact, price increases, impairment).
Market effects
Signals pressure in home medical equipment reimbursement economics and margin durability, potentially weighing on sentiment for similar providers.
U.S. West Coast capitated contract impact is cited as a headwind, highlighting regional reimbursement variability.
Primarily U.S.-focused healthcare services read-through; limited direct global impact.
Counterpoint
Management cites robust demand and record volume gains, suggesting the margin hit may be transition-related and could stabilize if execution improves.
Key entities
- companyAdaptHealth Corp.
Home medical equipment provider reporting Q2 2026 results and cutting full-year guidance.
- personSuzanne Foster
CEO cited for comments on robust demand but margin pressure from transition complexity.
